SCHEMBL13733459

SCHEMBL13733459

CC1(C)CN(C(=O)O)c2cc(C(=O)C3CCC3)cnc21

nearest known ligand 0.39

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
XIAP P98170 20/20 0.39
BIRC2 Q13490 14/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13733393 0.85 UCHL1 (0.36) XIAPBIRC2
SCHEMBL13733175 0.79 XIAP (0.37) XIAPBIRC2
SCHEMBL13733640 0.77 XIAP (0.50) XIAPBIRC2
SCHEMBL13733437 0.76 XIAP (0.36) XIAPBIRC2
SCHEMBL13732435 0.69 XIAP (0.56) XIAPBIRC2
SCHEMBL13732026 0.68 XIAP (0.64) XIAPBIRC2
SCHEMBL13733056 0.67 NR1H2 (0.38) XIAPBIRC2
SCHEMBL13732143 0.66 XIAP (0.54) XIAPBIRC2
SCHEMBL31725766 0.65 NOTUM (0.44)
Hydrochloric Acid SCHEMBL15649416 0.64 XIAP (0.36) XIAPBIRC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2699562-A1 BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPY Astex Therapeutics Limited (GB) 2014-02-26 EP disclosed
WO-2012143726-A1 BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPY ASTEX THERAPEUTICS LIMITED (GB) 2012-10-26 WO disclosed